ArticleAntimicrobial agents and chemotherapy2006
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02591901 (Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction), which is not on this map. Cited by 52 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method Study
Who cites it
52 citing papers in PubMed.
- Distinct Escherichia coli transcriptional profiles in the guts of recurrent UTI sufferers revealed by pangenome hybrid selection.Nature communications · 2024Article
- DistinctbioRxiv : the preprint server for biology · 2024Article
- Prevalence and antimicrobial susceptibility pattern of bacterial uropathogens among adult patients in Madinah, Saudi Arabia.BMC infectious diseases · 2023Article
- Multidrug resistance in pathogens of community-acquired urinary tract infections in Turkey: a multicentre prospective observational studyTurkish journal of medical sciences · 2023Observational
- A sublingual nanofiber vaccine to prevent urinary tract infections.Science advances · 2022Article
- Immunosuppression broadens evolutionary pathways to drug resistance and treatment failure during Acinetobacter baumannii pneumonia in mice.Nature microbiology · 2022Article
- Antibiotic Multidrug Resistance of Escherichia coli Causing Device- and Procedure-related Infections in the United States Reported to the National Healthcare Safety Network, 2013-2017.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Transcriptomic Analysis of the Activity and Mechanism of Action of a Ruthenium(II)-Based Antimicrobial That Induces Minimal Evolution of Pathogen Resistance.ACS pharmacology & translational science · 2021Article
- The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial KeratitisTurkish journal of ophthalmology · 2020Article
- Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- ProducingInfection and drug resistance · 2020Article
- Detection of Chromosomal and Plasmid-Mediated Quinolone Resistance AmongInfection and drug resistance · 2020Article
- Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.Prostate cancer and prostatic diseases · 2019Article
- Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation-The Example of FimH.Molecules (Basel, Switzerland) · 2018Review
- Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.Proceedings of the National Academy of Sciences of the United States of America · 2018Article
- Wicked: The untold story of ciprofloxacin.PLoS pathogens · 2018Article
- Detection of Plasmid-MediatedThe open microbiology journal · 2018Article
- Discovery of nicoyamycin A, an inhibitor of uropathogenic Escherichia coli growth in low iron environments.Chemical communications (Cambridge, England) · 2017Article
- Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.Expert opinion on drug discovery · 2017Review
- Fluoroquinolone antimicrobial drugs.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2017Article
- Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection.Proceedings of the National Academy of Sciences of the United States of America · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ciprofloxacin-resistant Escherichia coli isolates (n = 1,858) from outpatient midstream urine specimens at 40 North American clinical laboratories in 2004 to 2005 were frequently resistant to ampicillin (79.8% of isolates) and trimethoprim-sulfamethoxazole (66.5%); concurrent resistance to cefdinir (9.0%) or nitrofurantoin (4.0%) was less common. Only 10.8% of isolates were resistant to ciprofloxacin alone. Fluoroquinolone-resistant isolates of E. coli from urine were frequently multidrug resistant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.